FMR LLC - HTG MOLECULAR DIAGNOSTICS IN ownership

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 21 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2019$1,831,000
-59.0%
2,692,9760.0%0.00%
-100.0%
Q2 2019$4,470,000
-45.9%
2,692,976
-18.5%
0.00%0.0%
Q1 2019$8,257,000
-9.9%
3,302,852
-8.5%
0.00%0.0%
Q4 2018$9,164,000
-49.4%
3,607,849
+0.6%
0.00%
-50.0%
Q3 2018$18,120,000
+59.4%
3,588,045
+2.9%
0.00%
+100.0%
Q2 2018$11,371,000
-9.2%
3,488,045
+0.8%
0.00%0.0%
Q1 2018$12,526,000
+816.3%
3,460,345
+413.8%
0.00%
Q4 2017$1,367,000
+19.4%
673,4610.0%0.00%
Q3 2017$1,145,000
-36.1%
673,4610.0%0.00%
Q2 2017$1,791,000
-61.6%
673,4610.0%0.00%
-100.0%
Q1 2017$4,660,000
+208.8%
673,4610.0%0.00%
Q4 2016$1,509,000
-3.4%
673,4610.0%0.00%
Q3 2016$1,562,000
-10.8%
673,4610.0%0.00%
Q2 2016$1,751,000
-9.4%
673,4610.0%0.00%
Q1 2016$1,933,000
-34.2%
673,4610.0%0.00%
Q4 2015$2,936,000
-42.8%
673,4610.0%0.00%
-100.0%
Q3 2015$5,132,000
-31.7%
673,4610.0%0.00%0.0%
Q2 2015$7,509,000673,4610.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q1 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,675,889$6,797,0005.97%
PERKINS CAPITAL MANAGEMENT INC 449,950$1,143,0000.89%
Diametric Capital, LP 116,754$297,0000.23%
Granahan Investment Management 924,300$2,348,0000.17%
Requisite Energy Fund I LP 100,000$254,0000.10%
Requisite Capital Management, LLC 100,000$254,0000.10%
B. Riley Wealth Advisors, Inc. 250,000$635,0000.09%
Kalos Management, Inc. 74,420$179,0000.09%
Crow Point Partners, LLC 65,475$164,0000.03%
ARDSLEY ADVISORY PARTNERS LP 35,000$89,0000.02%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders